Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 10, Issue 8, Pages 1221-1240
Publisher
Informa UK Limited
Online
2011-08-22
DOI
10.1586/erv.11.79
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Attenuated poxvirus vectors MVA and NYVAC as promising vaccine cadidates against HIV/AIDS
- (2014) Mariano Esteban Human vaccines & immunotherapeutics
- Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles
- (2011) Paul A. Goepfert et al. JOURNAL OF INFECTIOUS DISEASES
- Adverse Events Following Smallpox Vaccination With ACAM2000 in a Military Population
- (2010) Thomas M. Beachkofsky et al. ARCHIVES OF DERMATOLOGY
- Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2010) R. J. Amato et al. CLINICAL CANCER RESEARCH
- Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
- (2010) T. K. Berthoud et al. CLINICAL INFECTIOUS DISEASES
- Oncolytic viruses as experimental treatments for malignant gliomas: Using a scourge to treat a devil
- (2010) Franz J. Zemp et al. CYTOKINE & GROWTH FACTOR REVIEWS
- 5T4-modified vaccinia Ankara: progress in tumor-associated antigen-based immunotherapy
- (2010) Robert J Amato EXPERT OPINION ON BIOLOGICAL THERAPY
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Cross-trial Analysis of Immunologic and Clinical Data Resulting From Phase I and II Trials of MVA-5T4 (TroVax) in Colorectal, Renal, and Prostate Cancer Patients
- (2010) Richard Harrop et al. JOURNAL OF IMMUNOTHERAPY
- Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration
- (2010) Marissa B. Wilck et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax
- (2010) Michael S. Seaman et al. JOURNAL OF INFECTIOUS DISEASES
- Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
- (2010) Jeffrey R. Currier et al. PLoS One
- A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers
- (2010) Hee-Chang Jang et al. VACCINE
- ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile
- (2010) Aysegul Nalca et al. Drug Design Development and Therapy
- A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C-Modified Vaccinia Ankara Virus Vaccine Candidate in Indian Volunteers
- (2009) Vadakkuppatu Devasenapathi Ramanathan et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Vaccinia virus vaccines: Past, present and future
- (2009) Bertram L. Jacobs et al. ANTIVIRAL RESEARCH
- Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine
- (2009) Adam Dangoor et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model
- (2009) C. A. Meseda et al. Clinical and Vaccine Immunology
- Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8
- (2009) Tomoya Saito JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of smallpox vaccines using variola neutralization
- (2009) I. K. Damon et al. JOURNAL OF GENERAL VIROLOGY
- Comparative Cell‐Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV‐1 Clade BgagVaccine Prime‐Boost Regimens
- (2009) David M. Asmuth et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies
- (2009) David A. Garber et al. PLoS One
- A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
- (2009) Alfred von Krempelhuber et al. VACCINE
- Oral Rabies Vaccination in North America: Opportunities, Complexities, and Challenges
- (2009) Dennis Slate et al. PLoS Neglected Tropical Diseases
- Myocarditis, Pericarditis, and Dilated Cardiomyopathy after Smallpox Vaccination among Civilians in the United States, January–October 2003
- (2008) Juliette Morgan et al. CLINICAL INFECTIOUS DISEASES
- Ischemic Cardiac Events during the Department of Health and Human Services Smallpox Vaccination Program, 2003
- (2008) David L. Swerdlow et al. CLINICAL INFECTIOUS DISEASES
- The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and Cancer
- (2008) Carmen Gomez et al. CURRENT GENE THERAPY
- Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer
- (2008) Scott S Tykodi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine
- (2008) Richard N Greenberg et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Clinical development of MVA-based therapeutic cancer vaccines
- (2008) Bruce Acres et al. Expert Review of Vaccines
- IMVAMUNE®: modified vaccinia Ankara strain as an attenuated smallpox vaccine
- (2008) Jeffrey S Kennedy et al. Expert Review of Vaccines
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in Primates
- (2008) P. Mooij et al. JOURNAL OF VIROLOGY
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
- (2008) Pierre-Alexandre Bart et al. VACCINE
- Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers
- (2008) A. Guimarães-Walker et al. VACCINE
- Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy
- (2008) Thomas C. Greenough et al. VACCINE
- EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
- (2008) Sheena McCormack et al. VACCINE
- Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults
- (2008) Sharon E. Frey et al. VACCINE
- Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge
- (2007) Kathleen A. Marriott et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started